Humira Clobbers Biosimilars in Battle for Part D Coverage Pricing, payer policies keep market leader on top Jun 06, 2024
Guselkumab Continues Winning Streak in Crohn's Disease Dual-acting IL-23 inhibitor tops placebo, ustekinumab in phase III trials May 22, 2024
Healthcare Use Reduced When Female Gastroenterologists See Patients Female patients appeared to derive the greatest benefit, researchers say May 21, 2024
Rare Pregnancy Problem Linked to Thiopurines, FDA Says Agency finds risk for intrahepatic cholestasis of pregnancy mostly in IBD, lupus patients May 03, 2024
Loss of Anti-TNF Treatment Response Common in Crohn's Disease Study identified factors and strategies for maintaining response Apr 22, 2024
TNF Inhibitors for IBD Linked to Kidney Function Declines Observational VA data support recommendations for monitoring with initiation Apr 16, 2024
Can an Autoimmunity Lead to Immune Deficiency? Studies may explain some cases of rare opportunistic infections Mar 20, 2024
Valley Fever Screens Found Lagging for Rheum Patients in Endemic Areas A significant issue for DMARD and steroid users in the American Southwest Mar 14, 2024
Risankizumab Beats Ustekinumab for Previously Treated Crohn's The IL-23 inhibitor led to more clinical remissions vs the IL-12/23 inhibitor Feb 26, 2024
Top-Down Treatment Superior to Step-Up Approach for Crohn's Disease Early intensive treatment should be standard for most patients, researchers argue Feb 26, 2024
AGA Backs Fecal Microbiota-Based Therapies for Recurrent C. Diff But new guidelines do not recommend use in inflammatory bowel disease or irritable bowel syndrome Feb 21, 2024
Dose Escalation With Infliximab Biosimilar Can Restore Responses in IBD Patients with ulcerative colitis and Crohn's also experienced improved clinical remission Feb 02, 2024
History of IBD Linked to Severe Outcomes in Patients Hospitalized for COVID IBD was associated with an increased risk of sepsis, shock, and acute kidney injury Feb 01, 2024
IBD Surgery Linked to Improved Patient-Reported Pain, Physical Health However, this was not the case for social, emotional outcomes Jan 31, 2024
Telehealth Option Increased IBD Clinic's Patient Retention More than 60% of patients had return IBD care delivered via telehealth Jan 30, 2024
Switching Twice With Infliximab Biosimilars Not Linked With IBD Flare Risk Reassuring findings for patients whose insurance requires a switch Jan 28, 2024
Early Anti-TNF Reduces Perianal Fistula Risk in Kids With Crohn's "Far better to prevent these complications than to treat them once they occur," says researcher Jan 28, 2024
Clinical Challenges: Integrating Diet Into Crohn's Disease Management Whole-foods dietary patterns should complement therapeutic regimens Dec 27, 2023
Ozanimod Did Not Appear to Lead to More Adverse Pregnancy Outcomes However, avoiding pregnancy when on the IBD/MS drug still advised Dec 19, 2023
Novel Oral Agent May Dial Down Ulcerative Colitis Severity Investigational drug missed primary endpoint, but yielded durable responses in early trial Dec 18, 2023
Shingles Vaccine Reduced Zoster Attacks in Patients With IBD Patients 50 and older saw benefits with vaccine, except in cases of complicated zoster Dec 18, 2023
Goodbye, Appendix. Hello, Crohn's Disease? Meta-analysis finds a possible connection, although high heterogeneity was an issue Dec 17, 2023
Red Meat Consumption Tied to Higher Chance of UC Flare But similar association not seen for other high fat foods Dec 17, 2023
National Database Study Finds Higher Risk for Barrett’s Esophagus in IBD But no greater chance of BE-tied malignancy for these patients Dec 16, 2023
Methotrexate Tied to Greater Risks for Older Patients With CKD FDA should consider warning labels based on study results, researchers argue Nov 28, 2023
Biologic Therapy for IBD Not Tied to Higher Risk of Major Heart Events Newer agents also associated with lower VTE risk versus non-advanced treatments Nov 28, 2023 video
How to Position the Growing Number of Therapies in IBD "Exciting time" to treat Crohn's disease and ulcerative colitis, expert says Nov 21, 2023 video
New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks More than half of patients not in early clinical response at week 12 responded by week 24 Nov 14, 2023 video
Stelara Biosimilar OK'd With Interchangeability But patent settlement may keep new product off market until 2025 Nov 01, 2023
Controversial Kratom Appeared to Cause Severe Ulcerative Colitis Flare Researchers strongly discourage its use in IBD patients Oct 24, 2023
New Oral Drug Approved for Ulcerative Colitis in Adults S1P receptor modulator etrasimod indicated for moderately to severely active disease Oct 13, 2023
Atopic Dermatitis Linked to Increased IBD Risk in Adults and Kids Risk increased with severity of atopic dermatitis across both groups, cohort study shows Aug 30, 2023
U.S. Unveils First 10 Drugs for Medicare Price Negotiations Treatments for heart failure, Crohn's disease, and diabetes make the list Aug 29, 2023
Doctors, Patients Try to Shame Insurers to Reverse Prior Auth Denials Many have taken to social media to get tests, drugs, and treatments approved Aug 27, 2023
TNF Blockers for IBD Tied to Risk for Immune-Mediated Diseases "Paradoxical" finding puzzles researchers Jul 22, 2023
Mirikizumab Benefit in UC Extends Into Maintenance Phase Twice as many responders achieved clinical remission at week 40 versus placebo Jun 28, 2023
Inflammatory Bowel Disease Linked With Increased Stroke Risk Swedish study is largest, with longest follow-up to date Jun 14, 2023
A Close Look at the Data Backing Upadacitinib's Approval in Crohn's Compared with placebo, the JAK inhibitor improved clinical remission and endoscopic response May 25, 2023
